Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH

BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) can advance, if untreated, to liver fibrosis, cirrhosis, hepatocellular carcinoma, liver failure and liver-related death. In the United States, NASH affects approximately 2–5% of the population an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Oniciu, Daniela Carmen, Hashiguchi, Taishi, Shibazaki, Yuichiro, Bisgaier, Charles L.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5976190/
https://ncbi.nlm.nih.gov/pubmed/29847555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0194568
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars